BRCA1 and hepatocellular carcinoma: Additionally, PALB2 mediates hepatocellular carcinoma immune microenvironment remodeling (dual regulation of immune suppression and T-cell infiltration) via the cGAS-STING pathway, depending on its binding status with BRCA1 (45)—a mechanism that may also regulate the CRC immune microenvironment.